Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Cell Therapy
 More »

  • SCT Licenses Worldwide Rights to Prostate Cancer Stem Cell Assets
    tissue, and have mined data for genes and signaling pathways that affect cell fate. ... helps explain how prostate cancer stem cells form a base for post-therapy recurrence. ...
    8-9-2013
  • Athersys Gets Up to $2.8M for Heart Attack Regen Med Program
    The grant is expected to provide up to $2.8 million in support over the course of the study in connection with study progress and milestone achievement. MultiStem cell therapy is a ...
    8-6-2013
  • What Junk DNA? It's an Operating System
    Noncoding gene sequences control gene expression and influence disease processes. In the August 1 issue of CELL , researchers from the Gene and Stem Cell Therapy Program at ...
    8-6-2013
  • Don't Call It "Junk DNA" Anymore
    Based in the institute's gene and stem cell therapy program, the researchers say they have unraveled a previously unknown mechanism for regulating the activity of genes, thus ...
    8-5-2013
  • Hematologic Diagnostics Go with the Flow
    ... in peripheral blood at 1 cell/mL. He has also worked on the detection of minimal residual disease in pediatric patients with acute lymphoblastic leukemia after induction therapy. ...
    8-1-2013
  • Molecular Imaging Driving Development
    ... It is portable inside a cell incubator for direct time-lapse imaging. Integrating the ... patients who were most likely to benefit from folate receptor (FR)-targeted therapy. Dr. ...
    8-1-2013
  • Big Need in IBD: Drugs to Slow Progression
    for those that justify initiation of therapy earlier in the course of IBD, as well as ... to identify biomarkers predisposing IBD patients to develop hepatosplenic T-cell lymphoma. ...
    8-1-2013
  • Do VSELs Hold Water?
    and in 2007, NeoStem, a New York-based biopharma company that describes itself as a leader in the emerging cell therapy market, exclusively licensed the rights to the technology . ...
    7-31-2013
  • $70M Stem Cell Clinic Development Plan Approved in California
    BioSciences to develop a therapy for the blood disorder beta-thalassemia. And in March, the organization announced a plan to set up a stem cell bank and approved nine ...
    7-26-2013
  • CRISPR/Cas Comes of Age-Almost
    ... Yanfang Fu, Ph.D., and colleagues at MGH used a human cell-based reporter assay to ... It will be interesting to begin to explore the use of these reagents for therapy, ...
    7-24-2013
  • Genentech Trumpets Phase III Results for CLL Candidate
    Genentech to gain both a Breakthrough Therapy Designation and Priority Review from FDA. ... The drug candidate is intended to induce direct cell death by binding to CD20. Rituxan ...
    7-24-2013
  • Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for...
    an interest in ibrutinib, an exciting potential therapy addressing the needs of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma and mantle cell lymphoma." ...
    7-18-2013
  • Seeing the Light: Mature Photoreceptors Made from Stem Cells
    Ali et al. an "important milestone on the road to developing a widely available cell therapy for blindness." "Photoreceptor precursors derived from threedimensional embryonic stem ...
    7-17-2013
  • ADC, BZL Aim Warheads at PSMA-Positive Prostate Cancers
    PSMA is a cell-surface antigen on prostate cancer cells, and PSMA levels correlate ... potentially breakthrough therapy translated into a clinic program as soon as possible." ...
    7-15-2013
  • Lentiviral Stem Cell Gene Therapy Shows Promise in Two Small...
    Two papers published online in advance in Science this week point to the potential of lentiviral hematopoietic stem cell gene therapy for debilitating inherited conditions. The ...
    7-11-2013
  • More »

    Journal Articles

  • Safety and Efficacy of a Genetic Vaccine targeting Telomerase...
    Alessandra Gavazza, George Lubas, Arthur Fridman, Daniela Peruzzi, Joseph A Impellizeri, Laura Luberto, Emanuele Marra, Giuseppe Roscilli, Gennaro Ciliberto, Luigi Aurisicchio
    Human Gene Therapy and Part B: Methods
    Safety and Efficacy of a Genetic Vaccine targeting Telomerase plus Chemotherapy for the therapy of canine B-cell lymphoma Human Gene Therapy and Part B: Methods Client-owned pet ...
  • Tat-PTD-modified Oncolytic Adenovirus Driven by the SCG3 Promoter...
    Chuan Jin, Di Yu, Matko Cancer, Berith Nilsson, Justyna Leja, Magnus Essand
    Human Gene Therapy and Part B: Methods
    and ASH1 Enhancer for Neuroblastoma Therapy Human Gene Therapy and Part B: Methods ... of the SCG3 gene can selectively drive transgene expression in neuroblastoma cell lines. ...
  • The Committee for Advanced Therapies' (CAT) reflection paper...
    Alessandro Aiuti, Giulio Cossu, Pablo de Felipe, Maria Cristina Galli, Gopalan Narayanan, Matthias Renner, Axel Stahlbom, Christian K Schneider, Caroline Voltz-Girolt
    Human Gene Therapy and Part B: Methods
    applications for Advanced Therapy Medicinal Products, which include gene therapy medicinal products, somatic cell therapy medicinal products and tissue engineered products. ...
  • Odontogenic Induction of Dental Stem Cells by ECM-Inspired 3...
    Sriram Ravindran, Youbin Zhang, Chun-Chieh Huang, Anne George
    Tissue Engineering, Part A
    Tissue Engineering, Part A Currently, root canal therapy is the only clinical treatment ... This treatment results in loss of tooth vitality. Somatic dental stem cell based tissue ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll